Have a personal or library account? Click to login
A Scoping Review of POLG-Related Cerebellar Ataxia: Insights and Clinical Perspectives Cover

A Scoping Review of POLG-Related Cerebellar Ataxia: Insights and Clinical Perspectives

Tremor and Other Hyperkinetic Movements
Volume 15 (2025): Issue 1
By: Stefania KalampokiniORCID,  Iraklis Keramidiotis,  Stylianos RavanidisORCID,  Piergiorgio LochnerORCID,  Vasilios K. KimiskidisORCID and  Georgios M. HadjigeorgiouORCID  
Open Access
|Nov 2025

References

  1. 1Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Ramos-Campo DJ, Belinchón-deMiguel P, Martinez-Guardado I, et al. Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities. Biomedicines. 2023;11(9). DOI: 10.3390/biomedicines11092488
    Back to article
  2. 2DiMauro S, Schon EA, Carelli V, Hirano M. The clinical maze of mitochondrial neurology. Nature reviews Neurology. 2013;9(8):429–44. DOI: 10.1038/nrneurol.2013.126
    Back to article
  3. 3Copeland WC. The mitochondrial DNA polymerase in health and disease. Sub-cellular biochemistry. 2010;50:211–22. DOI: 10.1007/978-90-481-3471-7_11
    Back to article
  4. 4Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations. Nature reviews Neurology. 2019;15(1):40–52. DOI: 10.1038/s41582-018-0101-0
    Back to article
  5. 5Kaguni LS. DNA polymerase gamma, the mitochondrial replicase. Annu Rev Biochem. 2004;73:293–320. DOI: 10.1146/annurev.biochem.72.121801.161455
    Back to article
  6. 6Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CM, et al. Simplifying the clinical classification of polymerase gamma (POLG) disease based on age of onset; studies using a cohort of 155 cases. J Inherit Metab Dis. 2020;43(4):726–36. DOI: 10.1002/jimd.12211
    Back to article
  7. 7Bender F, Timmann D, van de Warrenburg BP, Adarmes-Gómez AD, Bender B, Thieme A, et al. Natural History of Polymerase Gamma-Related Ataxia. Movement disorders: official journal of the Movement Disorder Society. 2021;36(11):2642–52. DOI: 10.1002/mds.28713
    Back to article
  8. 8Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S, et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain: a journal of neurology. 2006;129(Pt 7):1685–92. DOI: 10.1093/brain/awl097
    Back to article
  9. 9Winterthun S, Ferrari G, He L, Taylor RW, Zeviani M, Turnbull DM, et al. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology. 2005;64(7):1204–8. DOI: 10.1212/01.WNL.0000156516.77696.5A
    Back to article
  10. 10Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Brodtkorb E, et al. Status epilepticus in POLG disease: a large multinational study. Journal of neurology. 2024;271(8):5156–64. DOI: 10.1007/s00415-024-12463-5
    Back to article
  11. 11Martikainen MH, Ng YS, Gorman GS, Alston CL, Blakely EL, Schaefer AM, et al. Clinical, Genetic, and Radiological Features of Extrapyramidal Movement Disorders in Mitochondrial Disease. JAMA neurology. 2016;73(6):668–74. DOI: 10.1001/jamaneurol.2016.0355
    Back to article
  12. 12Schreglmann SR, Riederer F, Galovic M, Ganos C, Kägi G, Waldvogel D, et al. Movement disorders in genetically confirmed mitochondrial disease and the putative role of the cerebellum. Movement disorders: official journal of the Movement Disorder Society. 2018;33(1):146–55. DOI: 10.1002/mds.27174
    Back to article
  13. 13Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamaki M, et al. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet. 2005;77(3):430–41. DOI: 10.1086/444548
    Back to article
  14. 14Van Goethem G, Luoma P, Rantamäki M, Al Memar A, Kaakkola S, Hackman P, et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology. 2004;63(7):1251–7. DOI: 10.1212/01.WNL.0000140494.58732.83
    Back to article
  15. 15Van Goethem G, Martin JJ, Dermaut B, Löfgren A, Wibail A, Ververken D, et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscular disorders: NMD. 2003;13(2):133–42. DOI: 10.1016/S0960-8966(02)00216-X
    Back to article
  16. 16Synofzik M, Srulijes K, Godau J, Berg D, Schols L. Characterizing POLG ataxia: clinics, electrophysiology and imaging. Cerebellum. 2012;11(4):1002–11. DOI: 10.1007/s12311-012-0378-2
    Back to article
  17. 17Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet (London, England). 2004;364(9437):875–82. DOI: 10.1016/S0140-6736(04)16983-3
    Back to article
  18. 18Zeviani M, Simonati A, Bindoff LA. Ataxia in mitochondrial disorders. Handbook of clinical neurology. 2012;103:359–72. DOI: 10.1016/B978-0-444-51892-7.00022-X
    Back to article
  19. 19Schicks J, Synofzik M, Schulte C, Schöls L. POLG, but not PEO1, is a frequent cause of cerebellar ataxia in Central Europe. Movement disorders: official journal of the Movement Disorder Society. 2010;25(15):2678–82. DOI: 10.1002/mds.23286
    Back to article
  20. 20Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of internal medicine. 2018;169(7):467–73. DOI: 10.7326/M18-0850
    Back to article
  21. 21Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7(1):7. DOI: 10.1186/s40779-020-00238-8
    Back to article
  22. 22Verhoeven WM, Egger JI, Kremer BP, de Pont BJ, Marcelis CL. Recurrent major depression, ataxia, and cardiomyopathy: association with a novel POLG mutation? Neuropsychiatric disease and treatment. 2011;7:293–6. DOI: 10.2147/NDT.S20153
    Back to article
  23. 23Woodbridge P, Liang C, Davis RL, Vandebona H, Sue CM. POLG mutations in Australian patients with mitochondrial disease. Internal medicine journal. 2013;43(2):150–6. DOI: 10.1111/j.1445-5994.2012.02847.x
    Back to article
  24. 24Rossi M, Medina Escobar A, Radrizzani M, Tenembaum S, Perandones C, Merello M. Dystonia in a Patient with Autosomal-Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG Gene. Mov Disord Clin Pract. 2017;4(2):266–9. DOI: 10.1002/mdc3.12397
    Back to article
  25. 25Habek M, Barun B, Adamec I, Mitrović Z, Ozretić D, Brinar VV. Early-onset ataxia with progressive external ophthalmoplegia associated with POLG mutation: autosomal recessive mitochondrial ataxic syndrome or SANDO? Neurologist. 2012;18(5):287–9. DOI: 10.1097/NRL.0b013e318266f5a6
    Back to article
  26. 26Roshal D, Glosser D, Zangaladze A. Parieto-occipital lobe epilepsy caused by a POLG1 compound heterozygous A467T/W748S genotype. Epilepsy Behav. 2011;21(2):206–10. DOI: 10.1016/j.yebeh.2011.03.003
    Back to article
  27. 27Galassi G, Lamantea E, Invernizzi F, Tavani F, Pisano I, Ferrero I, et al. Additive effects of POLG1 and ANT1 mutations in a complex encephalomyopathy. Neuromuscular disorders: NMD. 2008;18(6):465–70. DOI: 10.1016/j.nmd.2008.03.013
    Back to article
  28. 28Janssen W, Quaegebeur A, Van Goethem G, Ann L, Smets K, Vandenberghe R, et al. The spectrum of epilepsy caused by POLG mutations. Acta neurologica Belgica. 2016;116(1):17–25. DOI: 10.1007/s13760-015-0499-8
    Back to article
  29. 29Hinnell C, Haider S, Delamont S, Clough C, Hadzic N, Samuel M. Dystonia in mitochondrial spinocerebellar ataxia and epilepsy syndrome associated with novel recessive POLG mutations. Movement disorders: official journal of the Movement Disorder Society. 2012;27(1):162–3. DOI: 10.1002/mds.23960
    Back to article
  30. 30Flønes IH, Tzoulis C. Movement disorders in mitochondrial disease: a clinicopathological correlation. Curr Opin Neurol. 2018;31(4):472–83. DOI: 10.1097/WCO.0000000000000583
    Back to article
  31. 31Bostan A, Glibert G, Dachy B, Dan B. Novel mutation in spacer region of POLG associated with ataxia neuropathy spectrum and gastroparesis. Auton Neurosci. 2012;170(1–2):70–2. DOI: 10.1016/j.autneu.2012.06.002
    Back to article
  32. 32Lax NZ, Hepplewhite PD, Reeve AK, Nesbitt V, McFarland R, Jaros E, et al. Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study. Journal of neuropathology and experimental neurology. 2012;71(2):148–61. DOI: 10.1097/NEN.0b013e318244477d
    Back to article
  33. 33Vernon HJ, Bindoff LA. Mitochondrial ataxias. Handbook of clinical neurology. 2018;155:129–41. DOI: 10.1016/B978-0-444-64189-2.00009-3
    Back to article
  34. 34Lopriore P, Ricciarini V, Siciliano G, Mancuso M, Montano V. Mitochondrial Ataxias: Molecular Classification and Clinical Heterogeneity. Neurol Int. 2022;14(2):337–56. DOI: 10.3390/neurolint14020028
    Back to article
  35. 35Vogel AP, Rommel N, Oettinger A, Horger M, Krumm P, Kraus EM, et al. Speech and swallowing abnormalities in adults with POLG associated ataxia (POLG-A). Mitochondrion. 2017;37:1–7. DOI: 10.1016/j.mito.2017.06.002
    Back to article
  36. 36Nicastro N, Ranza E, Antonarakis SE, Horvath J. Pure Progressive Ataxia and Palatal Tremor (PAPT) Associated with a New Polymerase Gamma (POLG) Mutation. Cerebellum. 2016;15(6):829–31. DOI: 10.1007/s12311-015-0749-6
    Back to article
  37. 37Mongin M, Delorme C, Lenglet T, Jardel C, Vignal C, Roze E. Progressive Ataxia and Palatal Tremor: Think about POLG Mutations. Tremor Other Hyperkinet Mov (N Y). 2016.6:382. DOI: 10.5334/tohm.329
    Back to article
  38. 38Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion. 2008;8(5–6):396–413. DOI: 10.1016/j.mito.2008.05.003
    Back to article
  39. 39Henao AI, Pira S, Herrera DA, Vargas SA, Montoya J, Castillo M. Characteristic brain MRI findings in ataxia-neuropathy spectrum related to POLG mutation. Neuroradiol J. 2016;29(1):46–8. DOI: 10.1177/1971400915621324
    Back to article
  40. 40Pedroso JL, de Rezende Pinto WBV, Barsottini OGP, Oliveira ASB. Should we investigate mitochondrial disorders in progressive adult-onset undetermined ataxias? Cerebellum & ataxias. 2020;7:13. DOI: 10.1186/s40673-020-00122-0
    Back to article
  41. 41Piekutowska-Abramczuk D, Kaliszewska M, Sułek A, Jurkowska N, Ołtarzewski M, Jabłońska E, et al. The frequency of mitochondrial polymerase gamma related disorders in a large Polish population cohort. Mitochondrion. 2019;47:179–87. DOI: 10.1016/j.mito.2018.11.004
    Back to article
  42. 42Paus S, Zsurka G, Baron M, Deschauer M, Bamberg C, Klockgether T, et al. Apraxia of lid opening mimicking ptosis in compound heterozygosity for A467T and W748S POLG1 mutations. Movement disorders: official journal of the Movement Disorder Society. 2008;23(9):1286–8. DOI: 10.1002/mds.22135
    Back to article
  43. 43Van Maldergem L, Besse A, De Paepe B, Blakely EL, Appadurai V, Humble MM, et al. POLG2 deficiency causes adult-onset syndromic sensory neuropathy, ataxia and parkinsonism. Ann Clin Transl Neurol. 2017;4(1):4–14. DOI: 10.1002/acn3.361
    Back to article
  44. 44Palin EJ, Hakonen AH, Korpela M, Paetau A, Suomalainen A. Mitochondrial recessive ataxia syndrome mimicking dominant spinocerebellar ataxia. Journal of the neurological sciences. 2012;315(1–2):160–3. DOI: 10.1016/j.jns.2011.11.028
    Back to article
  45. 45Viscomi C, Zeviani M. MtDNA-maintenance defects: syndromes and genes. J Inherit Metab Dis. 2017;40(4):587–99. DOI: 10.1007/s10545-017-0027-5
    Back to article
  46. 46Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C, et al. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat. 2008;29(9):E150–72. DOI: 10.1002/humu.20824
    Back to article
  47. 47Horvath R, Hudson G, Ferrari G, Fütterer N, Ahola S, Lamantea E, et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain: a journal of neurology. 2006;129(Pt 7):1674–84. DOI: 10.1093/brain/awl088
    Back to article
  48. 48Copeland WC. Defects of mitochondrial DNA replication. J Child Neurol. 2014;29(9):1216–24. DOI: 10.1177/0883073814537380
    Back to article
  49. 49Craig K, Ferrari G, Tiangyou W, Hudson G, Gellera C, Zeviani M, et al. The A467T and W748S POLG substitutions are a rare cause of adult-onset ataxia in Europe. Brain: a journal of neurology. 2007;130(Pt 4):E69; author reply E70. DOI: 10.1093/brain/awm009
    Back to article
  50. 50Nuzhnyi E, Seliverstov Y, Klyushnikov S, Krylova T, Tsygankova P, Bychkov I, et al. POLG-associated ataxias can represent a substantial part of recessive and sporadic ataxias in adults. Clinical neurology and neurosurgery. 2021;201:106462. DOI: 10.1016/j.clineuro.2020.106462
    Back to article
  51. 51Borsche M, Dulovic-Mahlow M, Baumann H, Tunc S, Lüth T, Schaake S, et al. POLG2-Linked Mitochondrial Disease: Functional Insights from New Mutation Carriers and Review of the Literature. Cerebellum. 2024;23(2):479–88. DOI: 10.1007/s12311-023-01557-x
    Back to article
  52. 52Papandreou A, Rahman S, Fratter C, Ng J, Meyer E, Carr LJ, et al. Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease. J Inherit Metab Dis. 2018;41(6):1275–83. DOI: 10.1007/s10545-018-0227-7
    Back to article
  53. 53Pelayo-Negro AL, Sánchez-Quintana C, Rodríguez-Oroz MC, Volpini V, Zeviani M, Tola-Arribas MA, et al. Screening for POLG W748S and A467T mutations in ataxia patients from Spain. Movement disorders: official journal of the Movement Disorder Society. 2012;27(10):1326. DOI: 10.1002/mds.25085
    Back to article
  54. 54Chan SS, Longley MJ, Copeland WC. The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit. J Biol Chem. 2005;280(36):31341–6. DOI: 10.1074/jbc.M506762200
    Back to article
  55. 55Milone M, Massie R. Polymerase gamma 1 mutations: clinical correlations. Neurologist. 2010;16(2):84–91. DOI: 10.1097/NRL.0b013e3181c78a89
    Back to article
  56. 56Catania A, Legati A, Peverelli L, Nanetti L, Marchet S, Zanetti N, et al. Homozygous variant in OTX2 and possible genetic modifiers identified in a patient with combined pituitary hormone deficiency, ocular involvement, myopathy, ataxia, and mitochondrial impairment. Am J Med Genet A. 2019;179(5):827–31. DOI: 10.1002/ajmg.a.61092
    Back to article
  57. 57Synofzik M, Srulijes K, Godau J, Berg D, Schöls L. Characterizing POLG ataxia: clinics, electrophysiology and imaging. Cerebellum. 2012;11(4):1002–11. DOI: 10.1007/s12311-012-0378-2
    Back to article
  58. 58Sullivan R, Yau WY, O’Connor E, Houlden H. Spinocerebellar ataxia: an update. Journal of neurology. 2019;266(2):533–44. DOI: 10.1007/s00415-018-9076-4
    Back to article
  59. 59Müller U. Spinocerebellar ataxias (SCAs) caused by common mutations. Neurogenetics. 2021;22(4):235–50. DOI: 10.1007/s10048-021-00662-5
    Back to article
  60. 60Schulte C, Synofzik M, Gasser T, Schöls L. Ataxia with ophthalmoplegia or sensory neuropathy is frequently caused by POLG mutations. Neurology. 2009;73(11):898–900. DOI: 10.1212/WNL.0b013e3181b78488
    Back to article
  61. 61Stephen CD, Schmahmann JD. Eye Movement Abnormalities Are Ubiquitous in the Spinocerebellar Ataxias. Cerebellum. 2019;18(6):1130–6. DOI: 10.1007/s12311-019-01044-2
    Back to article
  62. 62Mitoma H, Manto M, Hampe CS. Immune-mediated cerebellar ataxias: from bench to bedside. Cerebellum & ataxias. 2017;4:16. DOI: 10.1186/s40673-017-0073-7
    Back to article
  63. 63Coarelli G, Wirth T, Tranchant C, Koenig M, Durr A, Anheim M. The inherited cerebellar ataxias: an update. Journal of neurology. 2023;270(1):208–22. DOI: 10.1007/s00415-022-11383-6
    Back to article
  64. 64Shin HW, Park HK. Recent Updates on Acquired Hepatocerebral Degeneration. Tremor Other Hyperkinet Mov (N Y). 2017.7:463. DOI: 10.5334/tohm.379
    Back to article
  65. 65Meira AT, Arruda WO, Ono SE, Neto AC, Raskin S, Camargo CHF, et al. Neuroradiological Findings in the Spinocerebellar Ataxias. Tremor Other Hyperkinet Mov (N Y). 2019;9. DOI: 10.5334/tohm.516
    Back to article
  66. 66Klaes A, Reckziegel E, Franca MC Jr., Rezende TJ, Vedolin LM, Jardim LB, et al. MR Imaging in Spinocerebellar Ataxias: A Systematic Review. AJNR American journal of neuroradiology. 2016;37(8):1405–12. DOI: 10.3174/ajnr.A4760
    Back to article
  67. 67Jerath NU, Shy ME. Asymmetric Ataxia, Depression, Memory Loss, Epilepsy, and Axonal Neuropathy Associated with A Heterozygous DNA Polymerase Gamma Variant of Uncertain Significance, c1370G>a (R457Q). J Neuromuscul Dis. 2018;5(1):99–104. DOI: 10.3233/JND-170229
    Back to article
  68. 68Pedersen ZO, Holm-Yildiz S, Dysgaard T. Nutritional Interventions for Patients with Mitochondrial POLG-Related Diseases: A Systematic Review on Efficacy and Safety. International journal of molecular sciences. 2022;23(18). DOI: 10.3390/ijms231810658
    Back to article
  69. 69Zweers H, van Wegberg AMJ, Janssen MCH, Wortmann SB. Ketogenic diet for mitochondrial disease: a systematic review on efficacy and safety. Orphanet J Rare Dis. 2021;16(1):295. DOI: 10.1186/s13023-021-01927-w
    Back to article
  70. 70Pekeles H, Berrahmoune S, Dassi C, Cheung ACT, Gagnon T, Waters PJ, et al. Safety and efficacy of deoxycytidine/deoxythymidine combination therapy in POLG-related disorders: 6-month interim results of an open-label, single arm, phase 2 trial. EClinicalMedicine. 2024;74:102740. DOI: 10.1016/j.eclinm.2024.102740
    Back to article
  71. 71Blazquez-Bermejo C, Carreno-Gago L, Molina-Granada D, Aguirre J, Ramon J, Torres-Torronteras J, et al. Increased dNTP pools rescue mtDNA depletion in human POLG-deficient fibroblasts. FASEB J. 2019;33(6):7168–79. DOI: 10.1096/fj.201801591R
    Back to article
  72. 72Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, et al. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Annals of neurology. 2015;77(5):753–9. DOI: 10.1002/ana.24362
    Back to article
DOI: https://doi.org/10.5334/tohm.1027 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Apr 14, 2025
Accepted on: Oct 30, 2025
Published on: Nov 10, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
POLG mutation,
POLG-related ataxia,
cerebellar ataxia,
movement disorders,
phenotype-genotype

© 2025 Stefania Kalampokini, Iraklis Keramidiotis, Stylianos Ravanidis, Piergiorgio Lochner, Vasilios K. Kimiskidis, Georgios M. Hadjigeorgiou, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 15 (2025): Issue 1Next article